Developing Protocols for Modelling of Genetic Diseases Using Induced Pluripotent Stem Cells

Not yet recruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

July 1, 2020

Study Completion Date

July 1, 2028

Conditions
Genetic Disease
Interventions
PROCEDURE

Skin biopsy/Urine Collection/Blood Sample Collection

"Participant will meet clinician in a suitable local clinical setting, in select circumstances the clinician may attend the participants home. Clinician will collect a 5-7mm section of skin, the area may be numbed beforehand and stitches may be used to close the wound when required. The wound will be dressed if deemed necessary by medical professional.~Participant will meet clinician in a suitable local clinical setting, in select circumstances the clinician may attend the participants home. The clinician or phlebotomost will use a disposable needle to remove a blood sample (normally 50ml but could be up to 320ml for adults).~Participant will meet clinician in a suitable local clinical setting, in select circumstances the clinician may attend the participants home. The clinician or other nominated member of the clinical team will provide a sterile urine collection vessel and direct the volunteer to a suitable private toilet area to provide the sample."

All Listed Sponsors
lead

Kevin Bruce

INDUSTRY

NCT03612310 - Developing Protocols for Modelling of Genetic Diseases Using Induced Pluripotent Stem Cells | Biotech Hunter | Biotech Hunter